Ruxolitinib, oral

Geschwistercodes

• 6-009.0 – Olaparib, oral
• 6-009.1 – Ombitasvir-Paritaprevir-Ritonavir, oral
• 6-009.2 – Panobinostat, oral
• 6-009.5 – Secukinumab, parenteral
• 6-009.6 – Telaprevir, oral
• 6-009.7 – Trametinib, oral
• 6-009.8 – Vandetanib, oral
• 6-009.9 – Daclizumab, parenteral
• 6-009.b – Dinutuximab beta, parenteral
• 6-009.c – Elbasvir-Grazoprevir, oral
• 6-009.d – Elotuzumab, parenteral
• 6-009.e – Liposomales Irinotecan, parenteral
• 6-009.f – Migalastat, oral
• 6-009.g – Necitumumab, parenteral
• 6-009.h – Olaratumab, parenteral
• 6-009.j – Palbociclib, oral
• 6-009.k – Selexipag, oral
• 6-009.m – Sofosbuvir-Velpatasvir, oral
• 6-009.n – Trifluridin-Tipiracil, oral
• 6-009.p – Pembrolizumab, parenteral
• 6-009.q – Daratumumab, intravenös
• 6-009.r – Daratumumab, subkutan

Übernommen von 6-00: Applikation von Medikamenten